NSE · SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
Loading market information…
NSE · TTKHLTCARE.NS · INR
Stock price, dividends, earnings
Quote as of Oct 30, 2026, 09:59 AM UTC. Cached market data; not a live quote.
One-year closing-price history · INR. Historical prices are not a forecast.
TTK Healthcare Limited’s quoted price sits in the lower half of its reported 52-week range, 27.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
THE INCOME SIDE
TTK Healthcare Limited’s forward annual dividend is ₹10.00 per share, paid annual. The forward yield is 1.11% at the quoted price. Future payments can change.
Historical amounts are adjusted for stock splits. Understand ex-dividend and payment dates →
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow TTK Healthcare Limited’s reporting calendar.
THE COMPANY BEHIND THE TICKER
TTK Healthcare Limited is a diversified enterprise operating across multiple sectors in India and globally. Its extensive activities encompass animal welfare, offering veterinary therapeutic solutions and feed supplements. The human pharmaceuticals division provides a range of herbal and allopathic formulations. Within consumer products, the company is responsible for marketing and distributing items such as Woodward's Gripewater, the EVA cosmetics line, and Good Home scrubbers and air fresheners. Its medical devices segment manufactures and supplies artificial heart valves, in addition to developing orthopedic implants and surgical instruments. Furthermore, TTK Healthcare produces and markets protective devices, including male contraceptives. The food segment specializes in manufacturing and selling processed food items like potato and cereal-based pellets. Notably, the company also engages in map and atlas printing and publishing through its 'Others' segment. Founded in 1958 and headquartered in Chennai, India, TTK Healthcare Limited operates as a subsidiary of TT Krishnamachari & Co., Ltd.
Latest available per-share figures in INR. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 10:02 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
Completed calendar years and any current-year payments shown separately. Current-year totals are incomplete until all payments are made.
See annual income at the current dividend rate.
Assumes the annual dividend stays unchanged. Payments follow the company’s schedule. Excludes taxes, fees and currency changes.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
₹1,777.70+₹16.70 (+0.95%)
Sun Pharmaceutical Industries Limited’s quoted price sits in the lower half of its reported 52-week range, 13.15% below the high.
₹9,780.00+₹116.00 (+1.2%)
Divi's Laboratories Limited’s quoted price sits in the upper half of its reported 52-week range, 0.69% below the high.
₹885.20-₹35.90 (-3.9%)
Sigma Advanced Systems Limited’s quoted price sits in the upper half of its reported 52-week range, 24.02% below the high.
₹651.65-₹29.25 (-4.3%)
Bliss GVS Pharma Limited’s quoted price sits in the upper half of its reported 52-week range, 11.93% below the high.
₹19.30-₹1.11 (-5.44%)
Syncom Formulations (India) Limited’s quoted price sits in the upper half of its reported 52-week range, 29.79% below the high.
₹315.50-₹4.05 (-1.27%)
Suraksha Diagnostic Ltd.’s quoted price sits in the upper half of its reported 52-week range, 12.36% below the high.
₹215.00-₹6.94 (-3.13%)
Jagsonpal Pharmaceuticals Limited’s quoted price sits in the upper half of its reported 52-week range, 18.71% below the high.
₹304.50-₹8.35 (-2.67%)
Bajaj Healthcare Ltd’s quoted price sits in the lower half of its reported 52-week range, 37.72% below the high.
